CisoDGRC thus appears to be a promising candidate as a tool for targeted delivery of anti-agents for CD13−/αvβ3+ tumor cells, such as MCF-7 and MDA-MB-231 cell lines [14], [15]. Here, ANPEP is linked to neoplasm.